Xeris Biopharma Holdings, Inc. XERS
$6.84
▼ -2.02% 24H
About
Xeris Biopharma Holdings, Inc. is a biopharmaceutical company headquartered in Chicago, Illinois. It specializes in developing and commercializing therapies for chronic endocrine and neurological conditions, with a commercial portfolio featuring three key products: Recorlev for treating endogenous Cushing's syndrome in…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees394
TickerXERS
Statistics
Market Cap$1.18B
Revenue (TTM)$291.8M
Net Income$554000
Net Margin0.2%
EPS$0.00
P/E95.86
P/S3.68
P/B81.83
EV/EBITDA27.15
ROE4.0%
Dividend Yield—
Price$6.84
Data: Twelve Data · Revenue = mcap / P/S